Editorial comment
J Urol
.
2013 May;189(5):1810.
doi: 10.1016/j.juro.2012.11.188.
Epub 2013 Feb 8.
Authors
Phillip P Smith
1
,
George A Kuchel
Affiliation
1
Urology Division and University of Connecticut Center on Aging, University of Connecticut Health Center Farmington, Connecticut, USA.
PMID:
23398719
DOI:
10.1016/j.juro.2012.11.188
No abstract available
Publication types
Comment
MeSH terms
Botulinum Toxins, Type A / adverse effects*
Female
Humans
Male
Urinary Bladder, Overactive / drug therapy*
Urinary Retention / chemically induced*
Substances
Botulinum Toxins, Type A